Evidence map›Paper›PMID 33828534›Full record

ArticleFrontiers in endocrinology2021

Should Pediatric Endocrinologists Consider More Carefully When to Perform a Stimulation Test?

Arturo Penco, Benedetta Bossini, Manuela Giangreco, Viviana Vidonis, Giada Vittori, Nicoletta Grassi, Maria Chiara Pellegrin, Elena Faleschini, Egidio Barbi, Gianluca Tornese

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Arturo PencoUniversity of Trieste, Trieste, Italy.
Benedetta BossiniUniversity of Trieste, Trieste, Italy.
Manuela GiangrecoInstitute for Maternal and Child Health IRCCS "Burlo Garofolo", Trieste, Italy.
Viviana VidonisInstitute for Maternal and Child Health IRCCS "Burlo Garofolo", Trieste, Italy.
Giada VittoriInstitute for Maternal and Child Health IRCCS "Burlo Garofolo", Trieste, Italy.
Nicoletta GrassiInstitute for Maternal and Child Health IRCCS "Burlo Garofolo", Trieste, Italy.
Maria Chiara PellegrinInstitute for Maternal and Child Health IRCCS "Burlo Garofolo", Trieste, Italy.
Elena FaleschiniInstitute for Maternal and Child Health IRCCS "Burlo Garofolo", Trieste, Italy.
Egidio BarbiUniversity of Trieste, Trieste, Italy.
Gianluca TorneseInstitute for Maternal and Child Health IRCCS "Burlo Garofolo", Trieste, Italy.
IRCCS Materno Infantile Burlo Garofolo · ITUniversity of Trieste · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Pediatric endocrinology rely greatly on hormone stimulation tests which demand time, money and effort. The knowledge of the pattern of pediatric endocrinology stimulation tests is therefore crucial to optimize resources and guide public health interventions. Aim of the study was to investigate the distribution of endocrine stimulation tests and the prevalence of pathological findings over a year and to explore whether single basal hormone concentrations could have saved unnecessary stimulation tests. Methods: Retrospective study with data collection for pediatric endocrine stimulation tests performed in 2019 in a tertiary center. Results: Overall, 278 tests were performed on 206 patients. The most performed test was arginine tolerance test (34%), followed by LHRH test (24%) and standard dose Synachthen test (19%), while the higher rate of pathological response was found in insulin tolerance test to detect growth hormone deficiency (81%), LHRH test to detect central precocious puberty (50%) and arginine tolerance test (41%). No cases of non-classical-congenital adrenal hyperplasia were diagnosed. While 29% of growth hormone deficient children who performed an insulin tolerance test had a pathological peak cortisol, none of them had central adrenal insufficiency confirmed at low dose Synacthen test. The use of basal hormone determinations could save up to 88% of standard dose Synachthen tests, 82% of arginine tolerance + GHRH test, 61% of LHRH test, 12% of tests for adrenal secretion. Conclusion: The use of single basal hormone concentrations could spare up to half of the tests, saving from 32,000 to 79,000 euros in 1 year. Apart from basal cortisol level <108 nmol/L to detect adrenal insufficiency and IGF-1 <-1.5 SDS to detect growth hormone deficiency, all the other cut-off for basal hormone determinations were found valid in order to spare unnecessary stimulation tests.

Indexed as

AdolescentChildDiagnostic Tests, RoutineEndocrine System DiseasesEndocrinologistsFemaleHormonesHumansHydrocortisoneInsulin-Like Growth Factor IMaleRetrospective StudiesHormonesHydrocortisoneInsulin-Like Growth Factor Icentral adrenal insufficiencycentral precocious pubertycongenital adrenal hyperplasiaendocrinologic diseasesepidemiologygrowth hormone deficiencystimulation testsvisit and budget of health

Identifiers

PMID33828534
PMCPMC8021019
OpenAlexW3137800313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.